/Companies

Amolyt Pharma

19 known investors

Find your way into Amolyt Pharma

Sign up to see every warm intro you have to Amolyt Pharma

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Amolyt Pharma team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Developing therapeutic peptides targeting rare endocrine diseases (past investment).

Investors · 19

Also in the syndicate · 8

ATEMCredit Agricole CreationCTI Life SciencesInnobio 2 managed by Bpifrance InvestissementNovo Holdings (Novo Ventures)PontifaxRelyens Innovation Santé/Turenne CapitalTekla Capital Investment LLC

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Frequently asked questions

What does Amolyt Pharma do?
Developing therapeutic peptides targeting rare endocrine diseases (past investment).
Who are Amolyt Pharma's investors?
Amolyt Pharma's investors include Andera Partners, ATEM Capital Fund, CTI Life Sciences Fund L.P., EQT Life Sciences, Kurma Partners, Octalfa, Sofinnova Partners, Intermediate Capital Group and 3 more.